Chief Medical Officer, Dr. Aron Tendler gives exclusive commentary in Psychiatric Times, highlighting how Deep TMS provides hope for the 42%
of OCD patients who are treatment-resistant and emphasizes the success that Deep TMS has had as a non-invasive treatment.
Comments